Improved Real-Time Quaking Induced Conversion for Early Diagnostics of Creutzfeldt-Jakob Disease in Denmark
- PMID: 37047069
- PMCID: PMC10094695
- DOI: 10.3390/ijms24076098
Improved Real-Time Quaking Induced Conversion for Early Diagnostics of Creutzfeldt-Jakob Disease in Denmark
Abstract
Cerebrospinal fluid-based real-time quaking-induced conversion (CSF RT-QuIC) is currently the most prominent method for early detection of sporadic Creutzfeldt-Jakob disease (sCJD), the most common prion disease. CSF RT-QuIC delivers high sensitivity (>90%) and specificity (100%), which has been demonstrated by large ring-trial studies testing probable and definitive sCJD cohorts. Following the inclusion of CSF RT-QuIC in the revised European CJD Surveillance Network diagnostic criteria for sCJD, it has become a standard diagnostic procedure in many prion disease reference or surveillance centers around the world. In this study, we present the implementation of the second-generation CSF RT-QuIC (commonly known as Improved QuIC or IQ) at the Danish Reference Center for Prion Diseases (DRCPD). The method's sensitivity and specificity were evaluated and validated by analyzing 63 CSF samples. These 63 samples were also analyzed at the National CJD Research and Surveillance Unit (NCJDRSU), based at the University of Edinburgh, UK; analysis was carried out using the first generation or previous CSF RT-QuIC method (PQ). The sensitivity and specificity of PQ during tests at the NCJDRSU were 92% and 100%, respectively. Using these 63 CSF samples, the agreement between the two RT-QuIC generations at DRCPD and NCJDRSU prion laboratories was 100%.
Keywords: Creutzfeldt–Jakob disease—CJD; RT-QuIC; cerebrospinal fluid—CSF; early diagnostics; improved real-time quaking-induced conversion—IQ; neurodegenerative protein misfolding diseases; prion disease; prions; recombinant PrP production and storage.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Concordance of cerebrospinal fluid real-time quaking-induced conversion across the European Creutzfeldt-Jakob Disease Surveillance Network.Eur J Neurol. 2022 Aug;29(8):2431-2438. doi: 10.1111/ene.15387. Epub 2022 May 25. Eur J Neurol. 2022. PMID: 35524506 Free PMC article.
-
Real-time quaking-induced conversion assay using a small-scale substrate production workflow for the diagnosis of Creutzfeldt-Jakob disease.J Neurochem. 2023 Jul;166(2):403-413. doi: 10.1111/jnc.15841. Epub 2023 May 17. J Neurochem. 2023. PMID: 37163217
-
Rapid and sensitive RT-QuIC detection of human Creutzfeldt-Jakob disease using cerebrospinal fluid.mBio. 2015 Jan 20;6(1):e02451-14. doi: 10.1128/mBio.02451-14. mBio. 2015. PMID: 25604790 Free PMC article.
-
Amplification techniques and diagnosis of prion diseases.Rev Neurol (Paris). 2019 Sep-Oct;175(7-8):458-463. doi: 10.1016/j.neurol.2019.06.002. Epub 2019 Jul 8. Rev Neurol (Paris). 2019. PMID: 31296398 Review.
-
Role of different recombinant PrP substrates in the diagnostic accuracy of the CSF RT-QuIC assay in Creutzfeldt-Jakob disease.Cell Tissue Res. 2023 Apr;392(1):301-306. doi: 10.1007/s00441-022-03715-9. Epub 2022 Dec 20. Cell Tissue Res. 2023. PMID: 36536226 Free PMC article. Review.
Cited by
-
Fast-track neuropathological screening for neurodegenerative diseases.Free Neuropathol. 2024 Aug 6;5:5-16. doi: 10.17879/freeneuropathology-2024-5643. eCollection 2024 Jan. Free Neuropathol. 2024. PMID: 39118598 Free PMC article.
References
-
- Wilham J.M., Orrú C.D., Bessen R.A., Atarashi R., Sano K., Race B., Meade-White K.D., Taubner L.M., Timmes A., Caughey B. Rapid End-Point Quantitation of Prion Seeding Activity with Sensitivity Comparable to Bioassays. PLoS Pathog. 2010;6:e1001217. doi: 10.1371/journal.ppat.1001217. - DOI - PMC - PubMed
-
- Hermann P., Appleby B., Brandel J.P., Caughey B., Collins S., Geschwind M.D., Green A., Haïk S., Kovacs G.G., Ladogana A., et al. Biomarkers and diagnostic guidelines for sporadic Creutzfeldt-Jakob disease. Lancet Neurol. 2021;20:235–246. doi: 10.1016/S1474-4422(20)30477-4. Erratum in Lancet Neurol. 2021, 20, e3. - DOI - PMC - PubMed
-
- Hermann P., Laux M., Glatzel M., Matschke J., Knipper T., Goebel S., Treig J., Schulz-Schaeffer W., Cramm M., Schmitz M., et al. Validation and utilization of amended diagnostic criteria in Creutzfeldt-Jakob disease surveillance. Neurology. 2018;91:e331–e338. doi: 10.1212/WNL.0000000000005860. - DOI - PubMed
-
- McKenzie N., Piconi G., Culeux A., Hammarin A., Stergiou C., Tzartos S., Versleijen A.A.M., van de Geer J., Cras P., Cardone F., et al. Concordance of cerebrospinal fluid real-time quaking-induced conversion across the European Creutzfeldt–Jakob Disease Surveillance Network. Eur. J. Neurol. 2022;29:2431–2438. doi: 10.1111/ene.15387. - DOI - PMC - PubMed
-
- Groveman B.R., Orrú C.D., Hughson A.G., Bongianni M., Fiorini M., Imperiale D., Ladogana A., Pocchiari M., Zanusso G., Caughey B. Extended and direct evaluation of RT-QuIC assays for Creutzfeldt-Jakob disease diagnosis. Ann. Clin. Transl. Neurol. 2016;4:139–144. doi: 10.1002/acn3.378. - DOI - PMC - PubMed
MeSH terms
Substances
Supplementary concepts
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials